NEEMANAVAINEEMA NAVAI9667NAVAI, NEEMAAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1155 Pressler StHouston77030-3721TXAuthorship 1717043Authorship 1792592Authorship 1793563Authorship 1799161Authorship 1806303Authorship 1813561Authorship 1930904Authorship 195352312923188Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, Cai X, Wang ZThe Journal of biological chemistryIdentification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem. 2003 Oct 24; 278(43):41998-2005.J Biol Chem2003-08-15T00:00:002003Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor.18001794Erickson BA, Navai N, Patil M, Chang A, Gonzalez CMThe Journal of urologyA prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery. J Urol. 2008 Jan; 179(1):203-6.J Urol2007-11-14T00:00:002007A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery.18499188Casey JT, Erickson BA, Navai N, Zhao LC, Meeks JJ, Gonzalez CMThe Journal of urologyUrethral reconstruction in patients with neurogenic bladder dysfunction. J Urol. 2008 Jul; 180(1):197-200.J Urol2008-05-21T00:00:002008Urethral reconstruction in patients with neurogenic bladder dysfunction.18584853Navai N, Ramos P, Zhao LC, Meeks JJ, Nadler RB, Smith NDUrologyWhy not partial nephrectomy? Urology. 2008 Aug; 72(2):243-6.Urology2008-06-26T00:00:002008Why not partial nephrectomy?18930268Meeks JJ, Zhao LC, Navai N, Perry KT, Nadler RB, Smith NDThe Journal of urologyRisk factors and management of urine leaks after partial nephrectomy. J Urol. 2008 Dec; 180(6):2375-8.J Urol2008-10-18T00:00:002008Risk factors and management of urine leaks after partial nephrectomy.18986563Navai N, Erickson BA, Zhao LC, Okotie OT, Gonzalez CMInternational braz j urol : official journal of the Brazilian Society of UrologyComplications following urethral reconstructive surgery: a six year experience. Int Braz J Urol. 2008 Sep-Oct; 34(5):594-600; discussion 601.Int Braz J Urol2008-09-01T00:00:002008Complications following urethral reconstructive surgery: a six year experience.23239884Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJThe Journal of biological chemistryThe p63 protein isoform ?Np63a inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013 Feb 01; 288(5):3275-88.J Biol Chem2012-12-13T00:00:002012The p63 protein isoform ?Np63a inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.Genitourinary Medical OncologyMD AndersonARLENE ODELIASIEFKER-RADTKEARLENE ODELIA SIEFKER-RADTKE8840SIEFKER-RADTKE, ARLENE ODELIAAssociate ProfessorASHISHKAMATASHISH KAMAT8961KAMAT, ASHISHProfessorCHARLES CHUANHAIGUOCHARLES CHUANHAI GUO9349GUO, CHARLES CHUANHAIAssociate Professor8.688620.00848659270research areas7.562890.028580757coauthor of619.00614.119560similar to11102selected publicationsSURENAMATINSURENA MATIN9030MATIN, SURENAProfessorCOLIN PDINNEYCOLIN P DINNEY8624DINNEY, COLIN PProfessorAuthorship 2273452Authorship 2323731Authorship 23397011Authorship 2345701220059657Alphs HH, Navai N, K?hler TS, McVary KTThe journal of sexual medicinePreoperative clinical and diagnostic characteristics of patients who require delayed IPP after primary Peyronies repair. J Sex Med. 2010 Mar; 7(3):1262-8.J Sex Med2010-01-06T00:00:002010Preoperative clinical and diagnostic characteristics of patients who require delayed IPP after primary Peyronies repair.22385993Navai N, Wood CGUrologic oncologyEnvironmental and modifiable risk factors in renal cell carcinoma. Urol Oncol. 2012 Mar-Apr; 30(2):220-4.Urol Oncol2012-03-01T00:00:002012Environmental and modifiable risk factors in renal cell carcinoma.23911605Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CPThe Journal of urologyRefining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7.J Urol2013-07-30T00:00:002013Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.24121789Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, K?fer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman TNature geneticsFrequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013 Dec; 45(12):1428-30.Nat Genet2013-10-13T00:00:002013Frequent truncating mutations of STAG2 in bladder cancer.Authorship 246914115948738Navai N, Yap RL, Gupta R, Fraser TG, Gonzalez CMInternational journal of urology : official journal of the Japanese Urological AssociationInflammatory pseudotumor of the testis: a novel presentation of acute retroviral syndrome. Int J Urol. 2005 Apr; 12(4):424-6.Int J Urol2005-04-01T00:00:002005Inflammatory pseudotumor of the testis: a novel presentation of acute retroviral syndrome.Authorship 270402521457071Rebuck DA, Zhao LC, Helfand BT, Casey JT, Navai N, Perry KT, Nadler RBJournal of endourologySimple modifications in operating room processes to reduce the times and costs associated with robot-assisted laparoscopic radical prostatectomy. J Endourol. 2011 Jun; 25(6):955-60.J Endourol2011-04-02T00:00:002011Simple modifications in operating room processes to reduce the times and costs associated with robot-assisted laparoscopic radical prostatectomy.Authorship 2927611Authorship 2991231125528394Navai N, Matin SFEuropean urologyWords of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy. Eur Urol. 2015 Jan; 67(1):173-174.Eur Urol2014-11-25T00:00:002014Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy.26421586Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AMUrologic oncologyOutcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urol Oncol. 2016 Feb; 34(2):59.e1-8.Urol Oncol2015-10-01T00:00:002015Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience.74Professor10Assistant Professor14Associate ProfessorAuthorship 843441Authorship 844833Authorship 846773Authorship 847025Authorship 852564Authorship 855781Authorship 856420Authorship 859150Authorship 860007Authorship 865152Authorship 867246European UrologyPapillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy. European Urology. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin TherapyJournal of Robotic SurgeryIs the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up. Journal of Robotic Surgery. 3:201-207.Is the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-upJournal of UrologyPreoperative clinical and diagnostic characteristics of patients who require delayed ipp after primary Peyronie's repair. Journal of Urology. 184:1392-1393.Preoperative clinical and diagnostic characteristics of patients who require delayed ipp after primary Peyronie's repairUrologic Oncology: Seminars and Original InvestigationsOutcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy. Urologic Oncology: Seminars and Original Investigations. 34:59.e1-59.e8.Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapyAnnals of Surgical OncologyAnnals of Surgical Oncology. 1-5.Annals of Surgical OncologyEuropean Urology FocusAbsence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. European Urology Focus. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJournal of EndourologyIn vivo microwave-induced porcine kidney thermoablation. Journal of Endourology. 25:908-909.In vivo microwave-induced porcine kidney thermoablationJournal of EndourologyNoninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles - Commentary. Journal of Endourology. 25:909-910.Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles - CommentaryTranslational Andrology and UrologyRisk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Translational Andrology and Urology. 4:273-282.Risk based neoadjuvant chemotherapy in muscle invasive bladder cancerEuropean Urology, SupplementsIdentification and characterization of a ligand-regulated nuclear export signal in androgen receptor. European Urology, Supplements. 2.Identification and characterization of a ligand-regulated nuclear export signal in androgen receptorJournal of UrologyOncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy. Journal of Urology. 195:1646-1647.Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy28753837Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JBEuropean urology focusAbsence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Eur Urol Focus. 2018 09; 4(5):720-724.Eur Urol Focus2017-01-18T00:00:002017Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.true1ProfessorProfessorAuthorship 8896546D015653Procedures826220.723393CystectomyD001749Disorders29623300.398698Urinary Bladder NeoplasmsD001500Chemicals & Drugs773960.7817BCG VaccineD002295Disorders1579530.582542Carcinoma, Transitional CellAuthorship 9068472Authorship 9099104Authorship 9107064Authorship 9108291Authorship 9110861Authorship 9122019Authorship 9137865Authorship 9150134Authorship 91570210Authorship 9160148Authorship 9188797Authorship 9194218Authorship 9196506Authorship 92320712Authorship 9262659Authorship 9286494Authorship 9354326Authorship 9395504Authorship 939707926816830Jayaratna IS, Navai N, Dinney CPTranslational andrology and urologyRisk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Transl Androl Urol. 2015 Jun; 4(3):273-82.Transl Androl Urol2015-06-01T00:00:002015Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer.26994308Navai N, Dinney CPThe Journal of urologyOncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy. J Urol. 2016 06; 195(6):1646-7.J Urol2016-03-16T00:00:002016Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy.26922408Mmeje CO, Guo CC, Shah JB, Navai N, Grossman HB, Dinney CP, Kamat AMEuropean urologyPapillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Gu?rin Therapy: Implication for Clinical Trial Design. Eur Urol. 2016 11; 70(5):778-785.Eur Urol2016-02-24T00:00:002016Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Gu?rin Therapy: Implication for Clinical Trial Design.27387678Navai N, Benedict WF, Zhang G, Abraham A, Ainslie N, Shah JB, Grossman HB, Kamat AM, Dinney CPAnnals of surgical oncologyPhase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon a2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer. Ann Surg Oncol. 2016 11; 23(12):4110-4114.Ann Surg Oncol2016-07-07T00:00:002016Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon a2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer.27494900Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney COncotargetEmploying an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget. 2017 May 23; 8(21):34205-34222.Oncotarget2017-05-23T00:00:002017Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis.27628630Nadler RB, Casey JT, Zhao LC, Navai N, Smith ZL, Zhumkhawala A, Macejko AMJournal of robotic surgeryIs the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up. J Robot Surg. 2010 Jan; 3(4):201-7.J Robot Surg2009-11-19T00:00:002009Is the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up.28731777Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SFJournal of endourologyInduction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol. 2017 09; 31(9):946-953.J Endourol2017-07-21T00:00:002017Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.28941030Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DABJU internationalQuality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548.BJU Int2017-10-17T00:00:002017Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.29230008Chapin BF, Nguyen JN, Achim MF, Navai N, Williams SB, Prokhorova IN, Wang X, Tapia EMLN, Davis JW, Troncoso PProstate cancer and prostatic diseasesPositive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer. Prostate Cancer Prostatic Dis. 2018 06; 21(2):221-227.Prostate Cancer Prostatic Dis2017-12-11T00:00:002017Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer.28710901Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim JBJU internationalBaseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int. 2018 01; 121(1):69-76.BJU Int2017-08-16T00:00:002017Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer.28753816Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat AM, Campbell M, Dinney CEuropean urology focusImpact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus. 2017 12; 3(6):577-583.Eur Urol Focus2017-07-13T00:00:002017Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.28872778Li R, Metcalfe MJ, Ferguson JE, Mokkapati S, Nogueras Gonz?lez GM, Dinney CP, Navai N, McConkey DJ, Sahai SK, Kamat AMBJU internationalEffects of thiazolidinedione in patients with active bladder cancer. BJU Int. 2018 02; 121(2):244-251.BJU Int2017-09-23T00:00:002017Effects of thiazolidinedione in patients with active bladder cancer.29264217Biebighauser KC, Gao J, Rao P, Landon G, Pagliaro L, Dinney CPN, Karam J, Navai NAsian journal of urologyNon-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation. Asian J Urol. 2017 Apr; 4(2):124-127.Asian J Urol2016-08-26T00:00:002016Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation.29430505Li R, Metcalfe M, Kukreja J, Navai NBladder cancer (Amsterdam, Netherlands)Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review. Bladder Cancer. 2018 Jan 20; 4(1):31-40.Bladder Cancer2018-01-20T00:00:002018Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.29569824Mmeje CO, Benson CR, Nogueras-Gonz?lez GM, Jayaratna IS, Gao J, Siefker-Radtke AO, Kamat AM, Dinney CP, Navai N, Shah JBBJU internationalDetermining the optimal time for radical cystectomy after neoadjuvant chemotherapy. BJU Int. 2018 07; 122(1):89-98.BJU Int2018-04-23T00:00:002018Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.29557251Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY, Creel KM, Kamat AM, Dinney CP, Navai N, Shah JB, Wang XSSurgical innovationPatient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy. Surg Innov. 2018 Jun; 25(3):242-250.Surg Innov2018-03-20T00:00:002018Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy.30033071Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai NEuropean urology focusCost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2020 01 15; 6(1):88-94.Eur Urol Focus2018-07-20T00:00:002018Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort.30627879Marcus RK, Lillemoe HA, Rice DC, Mena G, Bednarski BK, Speer BB, Ramirez PT, Lasala JD, Navai N, Williams WH, Kim BJ, Voss RK, Gottumukkala VN, Aloia TAAnnals of surgical oncologyDetermining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol. 2019 Mar; 26(3):782-790.Ann Surg Oncol2019-01-09T00:00:002019Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis.30301695Li R, Tabayoyong WB, Guo CC, Gonz?lez GMN, Navai N, Grossman HB, Dinney CP, Kamat AMEuropean urologyPrognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease. Eur Urol. 2019 01; 75(1):8-10.Eur Urol2018-10-06T00:00:002018Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease.PathologyUrologyDepartment of UrologyUrologyBaylor College of MedicineSETHLERNERSETH LERNER29.70990600000000-95.402830000000002886LERNER, SETHProfessorAuthorship 9419021030864005Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, Gonz?lez GMN, Kamat AM, Pisters LL, Dinney CP, Navai NWorld journal of urologyThe role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Dec; 37(12):2691-2698.World J Urol2019-03-12T00:00:002019The role of metastatic burden in cytoreductive/consolidative radical cystectomy.Authorship 943900629804202Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SFWorld journal of urologySalvage topical therapy for upper tract urothelial carcinoma. World J Urol. 2018 Dec; 36(12):2027-2034.World J Urol2018-05-26T00:00:002018Salvage topical therapy for upper tract urothelial carcinoma.D065287Procedures1594740.613196Robotic Surgical Procedures23507396Dinney CP, Fisher MB, Navai N, O'Donnell MA, Cutler D, Abraham A, Young S, Hutchins B, Caceres M, Kishnani N, Sode G, Cullen C, Zhang G, Grossman HB, Kamat AM, Gonzales M, Kincaid M, Ainslie N, Maneval DC, Wszolek MF, Benedict WFThe Journal of urologyPhase I trial of intravesical recombinant adenovirus mediated interferon-a2b formulated in Syn3 for Bacillus Calmette-Gu?rin failures in nonmuscle invasive bladder cancer. J Urol. 2013 Sep; 190(3):850-6.J Urol2013-03-15T00:00:002013Phase I trial of intravesical recombinant adenovirus mediated interferon-a2b formulated in Syn3 for Bacillus Calmette-Gu?rin failures in nonmuscle invasive bladder cancer.Authorship 949134531200843Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Nogueras Gonz?lez GM, Navai N, Grossman HB, Dinney CP, Kamat AMEuropean urology oncologyUsing Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign. Eur Urol Oncol. 2019 05; 2(3):286-293.Eur Urol Oncol2018-09-10T00:00:002018Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.Authorship 955225331501083Lim AH, Narayan VM, Navai NEuropean urology oncologyThe Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial. Eur Urol Oncol. 2020 02; 3(1):102-103.Eur Urol Oncol2019-09-06T00:00:002019The Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial.Authorship 9612941431742674Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DACancerContemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. 2020 02 01; 126(3):506-514.Cancer2019-11-19T00:00:002019Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends.Authorship 961831431780139Williams WH, Cata JP, Lasala JD, Navai N, Feng L, Gottumukkala VBritish journal of anaesthesiaEffect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. Br J Anaesth. 2020 02; 124(2):164-172.Br J Anaesth2019-11-26T00:00:002019Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy.Authorship 975081231895682Pessoa R, Navai N, Kukreja JBUrologyEDITORIAL COMMENT. Urology. 2020 01; 135:64-65.Urology2020-01-01T00:00:002020EDITORIAL COMMENT.Authorship 9759971331953001Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai NUrologic oncologyRadical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol. 2020 04; 38(4):247-254.Urol Oncol2020-01-14T00:00:002020Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes.Authorship 979642832122956Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPNMolecular cancer research : MCRTCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Mol Cancer Res. 2020 06; 18(6):811-821.Mol Cancer Res2020-03-02T00:00:002020TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.Authorship 9954711032713807Westerman ME, Kokorovic A, Wang XS, Lim A, Garcia-Gonzalez A, Seif M, Wang R, Kamat AM, Dinney CPN, Navai NThe journal of sexual medicineRadical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis. J Sex Med. 2020 10; 17(10):1995-2004.J Sex Med2020-07-23T00:00:002020Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis.Authorship 1002711233046869Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, Kamat AM, Matin SF, Araujo JC, Shah AY, Msaouel P, Corn P, Wang J, Papadopoulos JN, Yadav SS, Blando JM, Duan F, Basu S, Liu W, Shen Y, Zhang Y, Macaluso MD, Wang Y, Chen J, Zhang J, Futreal A, Dinney C, Allison JP, Goswami S, Sharma PNature medicineNeoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med. 2020 12; 26(12):1845-1851.Nat Med2020-10-12T00:00:002020Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.Authorship 10052871033210440Brooks NA, Kokorovic A, Xiao L, Matulay JT, Li R, Ranasinghe WKB, Nagaraju S, Shen Y, Gao J, Navai N, Dinney CPN, Grossman HB, Kamat AMBJU internationalThe obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu?rin. BJU Int. 2021 07; 128(1):65-71.BJU Int2020-12-05T00:00:002020The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu?rin.Authorship 1007212933308972Kukreja JB, Seif MA, Mery MW, Incalcaterra JR, Kamat AM, Dinney CP, Shah JB, Feeley TW, Navai NUrologic oncologyUtilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers. Urol Oncol. 2021 04; 39(4):237.e1-237.e5.Urol Oncol2020-12-08T00:00:002020Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers.Authorship 1009374733484074Bree KK, Hensley PJ, Brooks NA, Matulay J, Li R, Nogueras Gonzalez GM, Navai N, Grossman HB, Matin SF, Dinney CPN, Kamat AMBJU internationalImpact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer. BJU Int. 2021 11; 128(5):568-574.BJU Int2021-02-15T00:00:002021Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.Authorship 1009988733502236Matulay JT, Li R, Hensley PJ, Brooks NA, Narayan VM, Grossman HB, Navai N, Dinney CPN, Kamat AMThe Journal of urologyContemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Gu?rin: Implications for Clinical Trial Design. J Urol. 2021 06; 205(6):1612-1621.J Urol2021-01-27T00:00:002021Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Gu?rin: Implications for Clinical Trial Design.Authorship 1012193933619985Kukreja JB, Li R, Narayan VM, Lim A, Seif M, Wang X, Kamat A, Dinney C, Navai NJournal of endourologyOncologic Equipoise Between Robotic and Open Radical Cystectomy. J Endourol. 2021 08; 35(8):1168-1176.J Endourol2021-04-16T00:00:002021Oncologic Equipoise Between Robotic and Open Radical Cystectomy.Authorship 1014009733734859Matulay JT, Li R, Hensley PJ, Brooks NA, Narayan VM, Grossman HB, Navai N, Dinney CPN, Kamat AMThe Journal of urologyReply by Authors. J Urol. 2021 06; 205(6):1620-1621.J Urol2021-03-18T00:00:002021Reply by Authors.Authorship 10155186Authorship 1015772833783950Hensley PJ, Bree KK, Brooks N, Matulay J, Li R, Nogueras Gonz?lez GM, Navai N, Grossman HB, Dinney CP, Kamat AMBJU internationalTime interval from transurethral resection of bladder tumour to bacille Calmette-Gu?rin induction does not impact therapeutic response. BJU Int. 2021 11; 128(5):634-641.BJU Int2021-05-05T00:00:002021Time interval from transurethral resection of bladder tumour to bacille Calmette-Gu?rin induction does not impact therapeutic response.33799686Zacharias NM, Wang L, Maity T, Li L, Millward SW, Karam JA, Wood CG, Navai NInternational journal of molecular sciencesProlyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo. Int J Mol Sci. 2021 Mar 11; 22(6).Int J Mol Sci2021-03-11T00:00:002021Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo.Authorship 1016612833872050Bree KK, Hensley PJ, Westerman ME, Kokorovic A, Nogueras-Gonzalez GM, Dinney CP, Kamat AM, Navai NThe Journal of urologyContemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. J Urol. 2021 Sep; 206(3):577-585.J Urol2021-04-19T00:00:002021Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy.Authorship 1017520833935020Hensley PJ, Bree KK, Brooks N, Matulay J, Li R, Nogueras-Gonzalez GM, Nagaraju S, Navai N, Grossman HB, Dinney CP, Kamat AMEuropean urology oncologyImplications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Gu?rin Therapy Outcomes. Eur Urol Oncol. 2022 06; 5(3):347-356.Eur Urol Oncol2021-04-29T00:00:002021Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Gu?rin Therapy Outcomes.Authorship 1020926634117914Bree KK, Hensley PJ, Brooks N, Matulay J, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AMWorld journal of urologyImpact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center. World J Urol. 2021 Nov; 39(11):4143-4149.World J Urol2021-06-12T00:00:002021Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center.Authorship 102411611Authorship 10241358Authorship 1024235834184926Hensley PJ, Bree KK, Campbell MT, Alhalabi O, Kokorovic A, Miest T, Nogueras-Gonzalez GM, Gao J, Siefker-Radtke AO, Guo CC, Navai N, Dinney CP, Kamat AMThe Journal of urologyProgression of Disease after Bacillus Calmette-Gu?rin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. J Urol. 2021 11; 206(5):1258-1267.J Urol2021-06-29T00:00:002021Progression of Disease after Bacillus Calmette-Gu?rin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.34186127Westerman ME, Bree KK, Kokorovic A, Frank J, Wang XS, Kamat AM, Dinney CPN, Navai NUrologyWhat Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs. Urology. 2021 11; 157:181-187.Urology2021-06-26T00:00:002021What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs.34195319Kokorovic A, Westerman ME, Krause K, Hernandez M, Brooks N, Dinney CPN, Kamat AM, Navai NBladder cancer (Amsterdam, Netherlands)Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate. Bladder Cancer. 2021 May 25; 7(2):243-252.Bladder Cancer2021-05-25T00:00:002021Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate.Authorship 1027245834348860Sood A, Keeley J, Palma-Zamora I, Novara G, Elshaikh M, Jeong W, Hensley P, Navai N, Peabody JO, Trinh QD, Rogers CG, Menon M, Abdollah FUrologic oncologyHigh-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival. Urol Oncol. 2022 02; 40(2):62.e1-62.e11.Urol Oncol2021-08-02T00:00:002021High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival.Authorship 10274091134372685Hensley PJ, Bree KK, Campbell MT, Alhalabi O, Kokorovic A, Miest T, Nogueras-Gonzalez GM, Gao J, Siefker-Radtke AO, Guo CC, Navai N, Dinney CP, Kamat AMThe Journal of urologyReply by Authors. J Urol. 2021 11; 206(5):1267.J Urol2021-08-10T00:00:002021Reply by Authors.Authorship 103234114Authorship 1032342234694143Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SAThe Journal of urologyRole of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558.J Urol2021-10-25T00:00:002021Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience.34694162Bree KK, Navai NThe Journal of urologyContemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply. J Urol. 2022 02; 207(2):476-477.J Urol2021-10-25T00:00:002021Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply.Authorship 1034635634847263Lobo N, Bree KK, Hensley PJ, Nogueras-Gonzalez GM, Abraham P, Navai N, Dinney CP, Kamat AMBJU internationalReduced-dose bacillus Calmette-Gu?rin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre. BJU Int. 2022 09; 130(3):323-330.BJU Int2021-12-13T00:00:002021Reduced-dose bacillus Calmette-Gu?rin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre.Authorship 1034867534854189Lobo N, Hensley PJ, Bree KK, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AMBJU internationalShould patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Gu?rin? BJU Int. 2022 10; 130(4):463-469.BJU Int2021-12-13T00:00:002021Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Gu?rin?Authorship 1035682534920986Lobo N, Hensley PJ, Bree KK, Nogueras-Gonzalez GM, Navai N, Dinney CP, Sylvester RJ, Kamat AMEuropean urology oncologyUpdated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin. Eur Urol Oncol. 2022 02; 5(1):84-91.Eur Urol Oncol2021-12-15T00:00:002021Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin.Authorship 10400591035039231Adibi M, McCormick B, Economides MP, Petros F, Xiao L, Guo C, Shah A, Kamat AM, Dinney C, Navai N, Gao J, Siefker-Radtke A, Matin SF, Campbell MTClinical genitourinary cancerFive and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2022 04; 20(2):176-182.Clin Genitourin Cancer2021-12-24T00:00:002021Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.Authorship 10445711335475152Alhalabi O, Campbell MT, Xiao L, Adriazola AC, Wilson NR, Siefker-Radtke AO, Corn PG, Zurita A, Jonasch E, Gao J, Adibi M, Kamat AM, Navai N, Pisters LL, Dinney C, Matin SF, Shah AYBJUI compassMultimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass. 2022 Jan; 3(1):37-44.BJUI Compass2021-10-11T00:00:002021Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma.Authorship 10471101535654885Cohen AB, Stump L, Krumholz HM, Cartiera M, Jain S, Scott Sussman L, Hsiao A, Lindop W, Ying AK, Kaul RL, Balcezak TJ, Tereffe W, Comerford M, Jacoby D, Navai NNPJ digital medicineAligning mission to digital health strategy in academic medical centers. NPJ Digit Med. 2022 Jun 02; 5(1):67.NPJ Digit Med2022-06-02T00:00:002022Aligning mission to digital health strategy in academic medical centers.Authorship 10488161635747385Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S, Tian F, Yao H, Kus P, Chen H, Weinstein JN, Navai N, Dinney C, Gao J, Theodorescu D, Logothetis C, Guo CC, Wang W, McConkey D, Wei P, Kimmel M, Czerniak BiScienceThe origin of bladder cancer from mucosal field effects. iScience. 2022 Jul 15; 25(7):104551.iScience2022-06-07T00:00:002022The origin of bladder cancer from mucosal field effects.Authorship 10492827Authorship 1049056735770497Bree KK, Hensley PJ, Lobo N, Brooks NA, Nogueras-Gonzalez GM, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AMThe Journal of urologyReply by Authors. J Urol. 2022 08; 208(2):290-291.J Urol2022-06-30T00:00:002022Reply by Authors.35770498Bree KK, Hensley PJ, Lobo N, Brooks NA, Nogueras-Gonzalez GM, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AMThe Journal of urologyAll High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Gu?rin Response in High-Grade Ta Tumors. J Urol. 2022 08; 208(2):284-291.J Urol2022-06-30T00:00:002022All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Gu?rin Response in High-Grade Ta Tumors.Authorship 10504961635811851Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S, Tian F, Yao H, Kus P, Chen H, Weinstein JN, Navai N, Dinney C, Gao J, Theodorescu D, Logothetis C, Guo CC, Wang W, McConkey D, Wei P, Kimmel M, Czerniak BiScienceErratum: The origin of bladder cancer from mucosal field effects. iScience. 2022 Jul 15; 25(7):104715.iScience2022-07-04T00:00:002022Erratum: The origin of bladder cancer from mucosal field effects.Authorship 106167310Authorship 10579902Authorship 105471113Authorship 10551121036250944Bree KK, Kokorovic A, Westerman ME, Hensley PJ, Brooks NA, Qiao W, Shen Y, Kamat AM, Dinney CP, Navai NThe Journal of urologyRepeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic. J Urol. 2023 01; 209(1):140-149.J Urol2022-10-11T00:00:002022Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.36404232Hensley PJ, Duan Z, Bree K, Sood A, Zhao H, Lobo N, Contieri R, Campbell MT, Guo CC, Navai N, Williams SB, Dinney CP, Kamat AMUrologic oncologyCompeting mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. Urol Oncol. 2023 02; 41(2):108.e11-108.e17.Urol Oncol2022-11-17T00:00:002022Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship.35961847Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SFUrologic oncologyLongitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23.Urol Oncol2022-08-10T00:00:002022Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.36010890Kamal M, Navai N, Bree KK, Williams LA, Cleeland CS, Shen SE, Wang XSCancersValidation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting. Cancers (Basel). 2022 Aug 12; 14(16).Cancers (Basel)2022-08-12T00:00:002022Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.Authorship 10707671037211780Bree KK, Kokorovic A, Westerman ME, Hensley PJ, Brooks NA, Qiao W, Shen Y, Kamat AM, Dinney CP, Navai NThe Journal of urologyRepeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply. J Urol. 2023 08; 210(2):254-255.J Urol2023-05-22T00:00:002023Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.Authorship 10743243Authorship 10739289Authorship 10734196Authorship 1073935837246493Tan WS, Grajales V, Bree K, Li R, Nogueras-Gonzalez GM, Navai N, Dinney C, Kamat AMBJU internationalBacillus Calmette-Gu?rin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal? BJU Int. 2023 10; 132(4):384-386.BJU Int2023-06-15T00:00:002023Bacillus Calmette-Gu?rin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?37297013Wang XS, Bree KK, Navai N, Kamal M, Shen SE, Letona E, Cleeland CS, Shi Q, Gottumukkala VCancersUtility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study. Cancers (Basel). 2023 Jun 04; 15(11).Cancers (Basel)2023-06-04T00:00:002023Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study.37442564Contieri R, Grajales V, Tan WS, Martini A, Sood A, Hensley P, Bree K, Lobo N, Nogueras-Gonzalez GM, Guo CC, Navai N, Dinney CP, Kamat AMBJU internationalImpact of age >70?years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu?rin. BJU Int. 2024 01; 133(1):63-70.BJU Int2023-08-02T00:00:002023Impact of age >70?years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu?rin.37441349Tan WS, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo CC, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AMEuropean urology open scienceBladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes. Eur Urol Open Sci. 2023 Jul; 53:16-22.Eur Urol Open Sci2023-05-13T00:00:002023Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes.Authorship 1075134637468392Tan WS, McElree IM, Davaro F, Steinberg RL, Bree K, Navai N, Dinney CP, O'Donnell MA, Li R, Kamat AM, Packiam VTEuropean urology oncologySequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Gu?rin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023 10; 6(5):531-534.Eur Urol Oncol2023-07-18T00:00:002023Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Gu?rin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer.Authorship 1078208837558542Contieri R, Hensley PJ, Tan WS, Grajales V, Bree K, Nogueras-Gonzalez GM, Lee BH, Navai N, Dinney CP, Kamat AMEuropean urology oncologyOncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin or Early Radical Cystectomy. Eur Urol Oncol. 2023 12; 6(6):590-596.Eur Urol Oncol2023-08-08T00:00:002023Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin or Early Radical Cystectomy.Authorship 10797382Authorship 1079737237747095Bree K, Navai NThe Journal of urologyRepeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply. J Urol. 2023 12; 210(6):839-840.J Urol2023-09-25T00:00:002023Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.37747096Bree KK, Navai NThe Journal of urologyRepeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply. J Urol. 2023 12; 210(6):839.J Urol2023-09-25T00:00:002023Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.Authorship 1080914837833193Alhalabi O, Wilson N, Xiao L, Lin Y, Khandelwal J, Moussa MJ, Msaouel P, Navai N, Gao J, Kamat AM, Pilie P, Shah AY, Goswami S, Matin S, Kovitz C, Holla V, Guo C, Czerniak B, Logothetis C, Corn PG, Dinney CPN, Campbell MT, Hansel DE, Tannir NM, Siefker-Radtke AOEuropean urology oncologyComparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. Eur Urol Oncol. 2023 12; 6(6):611-620.Eur Urol Oncol2023-10-11T00:00:002023Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.Authorship 10832111037922370Sood A, Rudzinski JK, Labbate CV, Hensley PJ, Bree KK, Guo CC, Alhalabi O, Campbell MT, Siefker-Radtke AO, Navai N, Dinney CPN, Gao J, Kamat AMThe Journal of urologyLong-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience. J Urol. 2024 Feb; 211(2):241-255.J Urol2023-11-03T00:00:002023Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience.Authorship 1089327938374533Contieri R, Tan WS, Grajales V, Hensley PJ, Martini A, Bree K, Myers A, Nogueras-Gonzalez G, Navai N, Dinney CP, Guo C, Kamat AMBJU internationalInfluence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU Int. 2024 Feb 19.BJU Int2024-02-19T00:00:002024Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.true1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor